Author

Thor Halfdanarson

Observed name: Thorvardur R Halfdanarson

Institution: Mayo Clinic

Observed institutions: University of Iowa, Mayo Clinic, University of Iowa Hospitals and Clinics, University of Iowa Health Care

OpenAlex ID: A5058594131

Development of a Highly Sensitive and Specific Carboxy-Terminal Human Pancreastatin Assay to Monitor Neuroendocrine Tumor Behavior

2010 · Thomas M. O'Dorisio, Siegfried R. Krutzik, et al. · Pancreas · 49

Update in the management of gastroenteropancreatic neuroendocrine tumors

2024 · Andrew J. H. Sedlack, Diana Grace Varghese, et al. · Cancer · 25

Development of a Highly Sensitive and Specific Carboxy-Terminal Human Pancreastatin Assay to Monitor Neuroendocrine Tumor Behavior

2010 · Thomas M. O'Dorisio, Siegfried R. Krutzik, et al. · Pancreas · 6

Approach to the patient: theranostics as precision medicine for neuroendocrine tumors

2026 · Regina Koch, Guillaume Pegna, et al. · The Journal of Clinical Endocrinology & Metabolism

The diagnostic accuracy of vasoactive intestinal peptide (VIP) for VIPoma

2025 · Jack Korleski, Velasquez Luis E. Ospina, et al. · Endocrine Abstracts

From neuroendocrine neoplasms to sarcomas: how genetic testing reveals diagnostic pitfalls

2025 · Oudai Sahvan, Bassam Sonbol, et al. · Endocrine Abstracts

Works count: 6

Citation count: 80

H-index: 3

I10-index: 2